Form D · Other
Beagle Bioproducts, Inc.
Columbus, OH · CIK 0001549001
Offering snapshot reported Oct 21, 2015 · SEC filing
- Reported sold
- $200K Offering amount: $1M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $20K Reported outside-investor minimum
- First sale
- Apr 1, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 21, 2015 | Initial | $200,000 | No comparison | 8 | SEC filing |
| Apr 4, 2013 | Initial | $60,000 | No comparison | 4 | SEC filing |
| Dec 17, 2012 | Amendment | $621,000 | $35,000vs Sep 21, 2012 | 27 | SEC filing |
| Sep 21, 2012 | Amendment | $586,000 | $206,000vs May 4, 2012 | 25 | SEC filing |
| May 4, 2012 | Initial | $380,000 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-249835
Source: Form D, filed Oct 21, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michelle Galligan | Director |
| Remsen Harris | Director |
| Eric P. Roy | Director, Executive |
| Stephanie A. Smith | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
959 Shrock Rd.
Columbus, OH, 43229
Columbus, OH, 43229